Autologous CMV-specific cytotoxic T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Autologous CMV-specific cytotoxic T cells, covering 2020-03-17 to 2023-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma [Phase 1, Phase 2]